These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 28975664

  • 1. Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
    Chetboul V, Pouchelon JL, Menard J, Blanc J, Desquilbet L, Petit A, Rougier S, Lucats L, Woehrle F, TEST study investigators.
    J Vet Intern Med; 2017 Nov; 31(6):1629-1642. PubMed ID: 28975664
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
    Besche B, Blondel T, Guillot E, Garelli-Paar C, Oyama MA.
    J Vet Intern Med; 2020 Sep; 34(5):1746-1758. PubMed ID: 32767627
    [Abstract] [Full Text] [Related]

  • 3. Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).
    Poissonnier C, Ghazal S, Passavin P, Alvarado MP, Lefort S, Trehiou-Sechi E, Saponaro V, Barbarino A, Delle Cave J, Marchal CR, Depré B, Vannucci E, Tissier R, Verwaerde P, Chetboul V.
    BMC Vet Res; 2020 Sep 16; 16(1):339. PubMed ID: 32938442
    [Abstract] [Full Text] [Related]

  • 4. Torasemide in chronic heart failure: results of the TORIC study.
    Cosín J, Díez J, TORIC investigators.
    Eur J Heart Fail; 2002 Aug 16; 4(4):507-13. PubMed ID: 12167392
    [Abstract] [Full Text] [Related]

  • 5. Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
    Peddle GD, Singletary GE, Reynolds CA, Trafny DJ, Machen MC, Oyama MA.
    J Vet Cardiol; 2012 Mar 16; 14(1):253-9. PubMed ID: 22364690
    [Abstract] [Full Text] [Related]

  • 6. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
    Müller K, Gamba G, Jaquet F, Hess B.
    Eur J Heart Fail; 2003 Dec 16; 5(6):793-801. PubMed ID: 14675858
    [Abstract] [Full Text] [Related]

  • 7. [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
    Spannheimer A, Müller K, Falkenstein P, Reitberger U, Gutzwiller F, Follath F.
    Praxis (Bern 1994); 2002 Sep 11; 91(37):1467-75. PubMed ID: 12360682
    [Abstract] [Full Text] [Related]

  • 8. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H, Ohtaki Y.
    Nihon Yakurigaku Zasshi; 2001 Aug 11; 118(2):97-105. PubMed ID: 11530685
    [Abstract] [Full Text] [Related]

  • 9. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
    Balsam P, Ozierański K, Tymińska A, Główczyńska R, Peller M, Fojt A, Cacko A, Sieradzki B, Bakuła E, Markulis M, Kowalik R, Huczek Z, Filipiak KJ, Opolski G, Grabowski M.
    Trials; 2017 Jan 23; 18(1):36. PubMed ID: 28114980
    [Abstract] [Full Text] [Related]

  • 10. A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
    Noe LL, Vreeland MG, Pezzella SM, Trotter JP.
    Clin Ther; 1999 May 23; 21(5):854-66. PubMed ID: 10397380
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
    Ozierański K, Balsam P, Kapłon-Cieślicka A, Tymińska A, Kowalik R, Grabowski M, Peller M, Wancerz A, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Filipiak KJ, Opolski G.
    Cardiovasc Drugs Ther; 2019 Feb 23; 33(1):77-86. PubMed ID: 30649675
    [Abstract] [Full Text] [Related]

  • 13. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
    TORAFIC Investigators Group.
    Clin Ther; 2011 Sep 23; 33(9):1204-1213.e3. PubMed ID: 21906812
    [Abstract] [Full Text] [Related]

  • 14. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
    Broekhuysen J, Deger F, Douchamps J, Ducarne H, Herchuelz A.
    Eur J Clin Pharmacol; 1986 Sep 23; 31 Suppl():29-34. PubMed ID: 3536530
    [Abstract] [Full Text] [Related]

  • 15. [Effects of various diuretics on cardiac function in rats with heart failure].
    Tanaka H, Watanabe K, Harima M, Thanikachalam PV, Yamaguchi K, Tachikawa H, Kodama M, Aizawa Y.
    Yakugaku Zasshi; 2009 Jul 23; 129(7):871-9. PubMed ID: 19571523
    [Abstract] [Full Text] [Related]

  • 16. [Update: prolonged-release torasemide].
    Acuña C.
    Drugs Today (Barc); 2010 Jul 23; 46 Suppl E():1-15. PubMed ID: 20882198
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial.
    Wess G, Kresken JG, Wendt R, Gaugele J, Killich M, Keller L, Simak J, Holler P, Bauer A, Küchenhof H, Glaus T.
    J Vet Intern Med; 2020 Nov 23; 34(6):2232-2241. PubMed ID: 32945575
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.